KIMI IGUCHI

CIK 1304815 · CFO & Treasurer · last filed 2024-08-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

49

Lifetime Open-Market Net

-$11.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sage Therapeutics, Inc. (SAGE) Delisted CFO & Treasurer 81,405 $8.68 $706.6K -$11.84M 49 2024-08-07

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-07-14 Sage Therapeutics, Inc. (SAGE) Delisted Sell (S) −5,000 -$247.8K EDGAR
2016-02-10 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2016-01-07 Sage Therapeutics, Inc. (SAGE) Delisted Mixed +4,176 $10.5K EDGAR
2015-09-09 Sage Therapeutics, Inc. (SAGE) Delisted Sell (S) −3,000 -$164.5K EDGAR
2015-08-11 Sage Therapeutics, Inc. (SAGE) Delisted Sell (S) −4,000 -$270.4K EDGAR
2015-07-06 Sage Therapeutics, Inc. (SAGE) Delisted Sell (S) −4,000 -$272.0K EDGAR
2015-06-08 Sage Therapeutics, Inc. (SAGE) Delisted Sell (S) −2,500 -$200.2K EDGAR
2015-01-27 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2014-07-23 Sage Therapeutics, Inc. (SAGE) Delisted Buy (P) +6,000 $108.0K EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.